Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve This is to inform that a meeting of ....
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Ltd has informed the stock exchanges that its Board of Directors will meet on Wednesday, August 13, 2025, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2025 (Q1 FY26). This is a routine advance intimation under SEBI's Listing Regulations, and the company's trading window for insiders has been closed since June 30, 2025, remaining so until 48 hours after the results are made public. No financial figures or business details have been disclosed in this filing — it is purely a notice of the upcoming board meeting.
This is a procedural filing with no direct impact on shareholders. Investors should watch for the Q1 FY26 results on August 13, 2025, which may influence short-term stock movement based on the pharma company's quarterly performance.